Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · January 26, 2016

Treat and Extend Regimen With Ranibizumab for Neovascular Age-Related Macular Degeneration

The British Journal of Ophthalmology

 

Additional Info

The British Journal of Ophthalmology
Changing From a Pro Re Nata Treatment Regimen to a Treat and Extend Regimen With Ranibizumab in Neovascular Age-Related Macular Degeneration
Br J Ophthalmol 2016 Jan 11;[EPub Ahead of Print], K Hatz, C Prünte

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading